Human SETD7 antibody

SETD7, SET7, SET9, SET7/9, SET7/9 Histone methyltransferase, SET domain-containing protein 8, SET domain-containing protein 7 FLJ21193, SET domain-containing protein 7, Lysine N-methyltransferase 7, Lysine methyltransferase, KMT7, KIAA1717, Histone-lysine N-methyltransferase SETD7, Histone-lysine N-methyltransferase, Histone lysine N methyltransferase H3 lysine 4 specific SET7, Histone lysine methyltransferase, Histone H4-K4 methyltransferase, Histone H3-K4 methyltransferase SETD7, Histone H3 lysine 4 specific methyltransferase, Histone H3 K4 methyltransferase, H4 lysine-4 specific, H3-K4-HMTase SETD7, H3 K4 HMTase, EC 2.1.1.43

SETD7, SET9, SET7/9 Histone methyltransferase, SET7/9, SET7, SET domain-containing protein 8, SET domain-containing protein 7 FLJ21193, SET domain-containing protein 7, SET domain containing protein 7, SET D7, SET 9, SET 7/9, SET 7, Lysine N-methyltransferase 7, Lysine methyltransferase, KMT7, KIAA1717, Histone-lysine N-methyltransferase SETD7, Histone-lysine N-methyltransferase, Histone lysine N methyltransferase H3 lysine 4 specific SET7, Histone lysine methyltransferase, Histone H4-K4 methyltransferase, Histone H3-K4 methyltransferase SETD7, Histone H3 lysine 4 specific methyltransferase, Histone H3 K4 methyltransferase, H4 lysine-4 specific, H3-K4-HMTase SETD7, H3 K4 HMTase, EC 2.1.1.43, ATGA0524-10 µg, ATGA0524-20 µg, ATGA0524-50 µg, ATGA0524-100 µg, ATGA0524-250 µg, ATGA0524-500 µg, ATGA0524-1 mg, ATGA0524-010, ATGA0524-020, ATGA0524-050, ATGA0524-100, ATGA0524-250, ATGA0524-500, ATGA0524-01M

Giannios I, et al. Protein Methyltransferase Inhibition Decreases Endocrine Specification Through the Upregulation of Aldh1b1 Expression. (Stem Cells. 2019) {https://pubmed.ncbi.nlm.nih.gov/30681750/}; ; Si W, et al. SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21. (Cell Death Dis. 2020) {https://pubmed.ncbi.nlm.nih.gov/32102992/}; ; Xie H, et al. METTL3/YTHDF2 m6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. (J Cell Mol Med. 2020) {https://pubmed.ncbi.nlm.nih.gov/32126149/}; ; Cao L, et al. Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway. (Int J Mol Med. 2020) {https://pubmed.ncbi.nlm.nih.gov/32323737/}; ; Jetton TL, et al. SetD7 (Set7/9) is a novel target of PPARγ that promotes the adaptive pancreatic β-cell glycemic response. (J Biol Chem. 2021) {https://pubmed.ncbi.nlm.nih.gov/34592314/}; ; Li X, et al. Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning. (J Clin Transl Hepatol. 2022) {https://pubmed.ncbi.nlm.nih.gov/35233374/}; ; Li J, et al. ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer. (Front Oncol. 2022) {https://pubmed.ncbi.nlm.nih.gov/35600335/}

The antibody has been tested by ELISA, Western blot, ICC/IF and FACS analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results

The Recombinant protein (50ng) was resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human SET7/9 antibody (1:1000) . Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.; ; Lane 1.: Recombinant human SET7/9 proteinThe Cell lysates (5ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human SET7/9 antibody (1:2000) . Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.; ; Lane 1.: 293T cell lysate; ; Lane 2.: SET7/9 transfected 293T cell lysate {2004010463430502.jpg}

Flow cytometry analysis of SET7/9 in Jurkat cells. The cell was stained with ATGA0524 at 2-5ug for 1x10^6cells (red) . A Goat anti mouse IgG (Alexa fluor 488) was used as the secondary antibody. Mouse monoclonal IgG was used as the isotype control (darkgray), cells without incubation with primary and secondary antibody was used as the negative control (light gray) .